Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in increased expression of NDP mRNA | affects cotreatment|increases expression | 17404688
|
D015735 |
Mifepristone |
Mifepristone results in decreased expression of NDP mRNA | decreases expression | 17584828
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NDP mRNA | affects binding|increases activity|increases expression | 19710929
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in increased expression of NDP mRNA | affects cotreatment|increases expression | 17404688
|
D011374 |
Progesterone |
Progesterone results in increased expression of NDP mRNA | increases expression | 17404688
|
D014051 |
Toluene 2,4-Diisocyanate |
Toluene 2,4-Diisocyanate results in increased expression of NDP mRNA | increases expression | 11379042
|
C025643 |
vinclozolin |
vinclozolin affects the expression of NDP mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.47 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.16 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.94 | 16434500 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.89 | 19015723 |
MESH:D001249 |
Asthma |
|
Toluene 2,4-Diisocyanate |
3.57 | 11467998 15590890 10797510 15590891 19187332 3040596 8156442 17015710 11077013 170078 12684321 10934080 16792590 7684630 16210060 18394133 6091946 6091945 20032816 11742282 15855793 12585506 12762349 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.47 | 19483382 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.86 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.68 | 15380490 15665606 15845082 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.08 | 12948864 19861407 18497071 17261762 17018787 17289903 14630087 16675129 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.08 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Toluene 2,4-Diisocyanate |
2.08 | 11921183 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Toluene 2,4-Diisocyanate |
4.79 | 15590891 12507178 8156442 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.93 | 16111702 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
1.79 | 16924424 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
2.98 | 18566989 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.05 | 19176532 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.72 | 14966744 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Toluene 2,4-Diisocyanate |
4.51 | 15491423 18759878 12956900 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.55 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
Toluene 2,4-Diisocyanate |
5.14 | 17010967 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.70 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.91 | 17187935 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.80 | 12083418 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
4.16 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.17 | 11473722 19148513 18566989 |
MESH:D004715 |
Endometriosis |
|
Mifepristone |
10.46 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
10.46 | 16134523 |
MESH:D004802 |
Eosinophilia |
|
Toluene 2,4-Diisocyanate |
5.07 | 8156442 |
OMIM:305390 |
EXUDATIVE VITREORETINOPATHY 2, X-LINKED |
marker/mechanism |
|
| |
MESH:D005128 |
Eye Diseases |
|
Toluene 2,4-Diisocyanate |
6.21 | 18447907 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
3.09 | 20131406 19236843 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.40 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.82 | 16417039 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.71 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.41 | 18467677 16221962 19176532 19772884 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.55 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.27 | 17088409 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.49 | 20558911 |
MESH:D006967 |
Hypersensitivity |
|
Toluene 2,4-Diisocyanate |
4.90 | 11019492 10880147 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.82 | 15869954 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
3.24 | 16467254 |
MESH:D007249 |
Inflammation |
|
Progesterone |
2.74 | 15869954 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.84 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.84 | 16306350 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.74 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
3.24 | 15610895 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
5.19 | 16417039 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
2.37 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.37 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.91 | 16377806 15890375 20007298 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.69 | 16891317 11807958 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
6.69 | 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
5.00 | 19453300 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.92 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.25 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
9.06 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
9.06 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.08 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
Toluene 2,4-Diisocyanate |
5.15 | 1670384 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
4.19 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
4.03 | 16427766 11399458 |
MESH:C537849 |
Norrie disease |
marker/mechanism |
|
| |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.87 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
Toluene 2,4-Diisocyanate |
5.02 | 3040596 11077013 18394133 6091945 12585506 8156442 6091946 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
8.47 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Mifepristone |
8.47 | 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
8.47 | 17393432 16525653 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
4.36 | 18220299 18042343 19015723 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.40 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.21 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.03 | 16740699 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.40 | 18629315 |
MESH:D011657 |
Pulmonary Eosinophilia |
|
Toluene 2,4-Diisocyanate |
6.14 | 14606601 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.52 | 19058328 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Toluene 2,4-Diisocyanate |
4.63 | 7692837 20219652 16940033 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Toluene 2,4-Diisocyanate |
5.64 | 18447907 |
MESH:D012220 |
Rhinitis |
|
Toluene 2,4-Diisocyanate |
4.88 | 19050374 |
MESH:D012221 |
Rhinitis, Allergic, Perennial |
|
Toluene 2,4-Diisocyanate |
5.80 | 12617775 15015336 |
MESH:D006255 |
Rhinitis, Allergic, Seasonal |
|
Toluene 2,4-Diisocyanate |
6.03 | 19075512 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.94 | 18045962 |
MESH:D012912 |
Sneezing |
|
Toluene 2,4-Diisocyanate |
6.03 | 19075512 19050374 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.74 | 16503802 15862959 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
5.21 | 19048282 |